Cargando…

CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid

BACKGROUND: Clinical trials designed to test the efficacy of retinoic acid (RA) as an adjuvant for the treatment of solid cancers have been disappointing, primarily due to RA resistance. Estrogen receptor (ER)-negative breast cancer cells are more resistant to RA than ER-positive cells. The expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Rong-Zong, Garcia, Elizabeth, Glubrecht, Darryl D., Poon, Ho Yin, Mackey, John R., Godbout, Roseline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491424/ https://www.ncbi.nlm.nih.gov/pubmed/26142905 http://dx.doi.org/10.1186/s12943-015-0380-7

Ejemplares similares

CRABP1 in Non-Canonical Activities of Retinoic Acid in Health and Diseases
por: Nhieu, Jennifer, et al.
Publicado: (2022)

Disabled-1 Alternative Splicing in Human Fetal Retina and Neural Tumors
por: Katyal, Sachin, et al.
Publicado: (2011)

AP-2ε Expression in Developing Retina: Contributing to the Molecular Diversity of Amacrine Cells
por: Jain, Saket, et al.
Publicado: (2018)

Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas
por: Percicote, Ana Paula, et al.
Publicado: (2018)

Resveratrol Reverses Retinoic Acid Resistance of Anaplastic Thyroid Cancer Cells via Demethylating CRABP2 Gene
por: Liu, Xin, et al.
Publicado: (2019)

The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease
por: Welch, Ian D, et al.
Publicado: (2009)

All-trans Retinoic Acid as a Versatile Cytosolic Signal Modulator Mediated by CRABP1
por: Nagpal, Isha, et al.
Publicado: (2019)

A new regulatory mechanism for Raf kinase activation, retinoic acid-bound Crabp1
por: Park, Sung Wook, et al.
Publicado: (2019)

Differential CRABP-II and FABP5 expression patterns and implications for medulloblastoma retinoic acid sensitivity
por: Zhang, Song, et al.
Publicado: (2018)

The FABP12/PPARγ pathway promotes metastatic transformation by inducing epithelial‐to‐mesenchymal transition and lipid‐derived energy production in prostate cancer cells
por: Liu, Rong‐Zong, et al.
Publicado: (2020)

CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid
por: Xia, Shi-Lin, et al.
Publicado: (2015)

An Amplified Fatty Acid-Binding Protein Gene Cluster in Prostate Cancer: Emerging Roles in Lipid Metabolism and Metastasis
por: Liu, Rong-Zong, et al.
Publicado: (2020)

CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status
por: Feng, Xuefei, et al.
Publicado: (2019)

The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer
por: Pandya, Vrajesh, et al.
Publicado: (2016)

Publisher Correction: A new regulatory mechanism for Raf kinase activation, retinoic acid-bound Crabp1
por: Park, Sung Wook, et al.
Publicado: (2019)

CRABPs Alter all-trans-Retinoic Acid Metabolism by CYP26A1 via Protein-Protein Interactions
por: Yabut, King Clyde B., et al.
Publicado: (2022)

Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance
por: Bekele, Raie T., et al.
Publicado: (2016)

Loss of AP-2delta reduces retinal ganglion cell numbers and axonal projections to the superior colliculus
por: Li, Xiaodong, et al.
Publicado: (2016)

All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation
por: Persaud, Shawna D., et al.
Publicado: (2016)

N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target
por: Mackey, John R., et al.
Publicado: (2021)

Corrigendum: All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation
por: Persaud, Shawna D., et al.
Publicado: (2016)

BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer
por: Pandya, Vrajesh, et al.
Publicado: (2020)

High Expression of KIF26B in Breast Cancer Associates with Poor Prognosis
por: Wang, Qun, et al.
Publicado: (2013)

Arpin downregulation in breast cancer is associated with poor prognosis
por: Lomakina, Maria E, et al.
Publicado: (2016)

Dezocine inhibits cell proliferation, migration, and invasion by targeting CRABP2 in ovarian cancer
por: Zhang, Chuanfeng, et al.
Publicado: (2022)

Correction: High Expression of KIF26B in Breast Cancer Associates with Poor Prognosis
por: Wang, Qun, et al.
Publicado: (2013)

4-Amino-2-trifluoromethyl-phenyl retinate inhibits proliferation, invasion, and migration of breast cancer cells by independently regulating CRABP2 and FABP5
por: Ju, Jing, et al.
Publicado: (2018)

OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer
por: Kim, Jae-Hwan, et al.
Publicado: (2015)

Overexpression of the cellular retinoic acid binding protein-I (CRABP- I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells
Publicado: (1991)

CRABP-I Expression Patterns in the Developing Chick Inner Ear
por: Cardeña-Núñez, Sheila, et al.
Publicado: (2023)

Partial PTEN deletion is linked to poor prognosis in breast cancer
por: Lebok, P., et al.
Publicado: (2015)

CYC1 Predicts Poor Prognosis in Patients with Breast Cancer
por: Han, Yingyan, et al.
Publicado: (2016)

LINC00978 predicts poor prognosis in breast cancer patients
por: Deng, Lin-lin, et al.
Publicado: (2016)

LAMP1 expression is associated with poor prognosis in breast cancer
por: Wang, Qingqing, et al.
Publicado: (2017)

Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
por: Lu, Wenjie, et al.
Publicado: (2020)

TZAP Mutation Leads to Poor Prognosis of Patients with Breast Cancer †
por: Heo, Yu-Ran, et al.
Publicado: (2019)

Overexpression of MAL2 Correlates with Immune Infiltration and Poor Prognosis in Breast Cancer
por: Zhong, Yue, et al.
Publicado: (2021)

CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression
por: Yu, Shuiliang, et al.
Publicado: (2016)

Plasma CRABP2 as a Novel Biomarker in Patients with Non-Small Cell Lung Cancer
por: Kim, Do Jun, et al.
Publicado: (2018)

Macrophages in Breast Cancer: Do Involution Macrophages Account for the Poor Prognosis of Pregnancy-Associated Breast Cancer?
por: O’Brien, Jenean, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_85rdoib5a8rbrkb3orujji1dfa